ArchiMed is a private equity general partner firm headquartered in Lyon, France.
Healthcare-focused PE firm ArchiMed has made a 400% IRR on its first exit, divesting France-based company HIS in a trade sale.
ArchiMed acquired health ingredients makers HIS and Fytexia; Polyplus, a maker of transfection reagents; and neurodiagnostic firm Micromed.
Healthcare-dedicated buyout house Archimed has fully acquired Italian medical devices manufacturer Micromed.
Read more news concerning ArchiMed
A sampling of ArchiMed portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?